摘要
目的 探究为治疗小儿细菌性脑膜炎,选择应用鞘内注射两性霉素B+5-氟胞嘧啶治疗的效果。方法 本医院所有患儿均采用计算机随机分组,60例小儿细菌性脑膜炎患者被平均分为观察组(n=30)和对照组(n=30),前者应用鞘内注射两性霉素B+5-氟胞嘧啶,后者用静脉滴注两性霉素B和5-氟胞嘧啶,实施时间为2021年1月至2022年1月。将两组患儿的临床疗效、相关恢复时间指标进行比较。结果 在总有效率控制方面,两组数据差异很大,观察组、对照组分别为96.67%、86.67%(P<0.05);在白细胞恢复正常、体温恢复正常以及住院时间对照上,观察组分别为(6.35±1.25)d、(10.65±2.18)d、(15.35±5.24)d,与对照组(8.63±2.10)d、(12.25±2.45)d、(21.03±5.52)d相比,前者明显较短(P<0.05)。结论 为治疗小儿细菌性脑膜炎,选择应用鞘内注射两性霉素B+5-氟胞嘧啶治疗疗效明显,可缩短患儿的恢复时间。
关键词: 两性霉素B+5-氟胞嘧啶;鞘内注射;小儿细菌性脑膜炎
Abstract
Objective To investigate the effect of intrathecal amphotericin B+5-fluorocytosine injection on bacterial meningitis in children. Methods All children in our hospital were randomly divided into two groups by computer. Sixty children with bacterial meningitis were equally divided into the observation group (n=30) and the control group (n=30). The former received intrathecal amphotericin B+5-fluorocytosine, and the latter received intravenous amphotericin B and 5-fluorocytosine. The implementation time was from January 2021 to January 2022. The clinical efficacy and relevant recovery time indexes of the two groups were compared. Results In terms of total effective rate control, there was a great difference between the two groups, 96.67% in the observation group and 86.67% in the control group (P<0.05); On the control of white blood cells returning to normal, body temperature returning to normal and hospital stay, the observation group was (6.35±1.25) d, (10.65±2.18) d, (15.35±5.24) d respectively, which was significantly shorter than the control group (8.63±2.10) d, (12.25±2.45) d, and (21.03±5.52) d (P<0.05). Conclusion In order to treat bacterial meningitis in children, intrathecal amphotericin B+5-fluorocytosine injection is effective and can shorten the recovery time of children.
Key words: Amphotericin B+5-fluorocytosine; Intrathecal injection; Bacterial meningitis in children
参考文献 References
[1] 刘冬梅.美罗培南联合万古霉素治疗小儿难治性细菌性脑膜炎的临床效果观察[J].临床合理用药杂志,2020,13(14):47-48.
[2] 梁森全,莫庆仪,黄晓雯,葛晓宁.利奈唑胺、万古霉素联合美罗培南对小儿细菌性脑膜炎脑脊液细胞学及远期疗效的影响[J].中国医药科学,2021,11(09):67-70+86.
[3] 杨露,刘佳,江滢,王翼洁,徐晓峰,甘周庆,陈灼林,彭福华.两性霉素B快速加量治疗隐球菌性脑膜炎疗效和安全性分析[J].中国神经精神疾病杂志,2021,47(06):348-354.
[4] 王辉,代洪,马静,李侗曾,牟丹蕾.两性霉素B联合氟康唑对获得性免疫缺陷综合征合并新生隐球菌性脑膜炎患者细胞免疫功能的影响[J].中国医药,2022,17(02):254-257.
[5] 何花,黄瑛,张燕玲,徐俊,李文明,罗云.不同剂量两性霉素B鞘内注射联合脑脊液持续引流置换治疗新型隐球菌性脑膜炎的对比[J].昆明医科大学学报,2020,41(12):112-118.
[6] 周晓华,李彩霞,林广裕,林创兴,蔡晓莹,陈派镇.细菌性脑膜炎患儿抗生素有效治疗后脑脊液白细胞计数持续异常的临床分析[J].汕头大学医学院学报,2021,34(04):221-225.
[7] 蔡文仙,李秋波,孙广斐,郑钦亮.儿童细菌性脑膜炎与病毒性脑炎氧化应激水平的变化及意义[J].中国实用神经疾病杂志,2020,23(01):66-69.
[8] 徐助伟,邓雯秋,刘焱斌.两性霉素B联合氟胞嘧啶及氟康唑治疗非HIV感染、非器官移植后隐球菌脑膜炎45例临床研究[J].中国感染与化疗杂志,2020,20(04):396-400.
[9] 林再红,李凤华,姜岩,杜姝,金艳,刘晶,傅增辉.两性霉素B通过NF-κB通路对小鼠隐球菌性脑膜炎脑组织中小胶质细胞及炎性因子的影响[J].免疫学杂志,2020,36(06):475-481.
[10] 杨露,刘君宇,徐晓峰,刘佳,江滢,彭福华.两性霉素B脂质体治疗隐球菌性脑膜炎药物浓度及其与疗效关系的研究[J].热带医学杂志,2022,22(03):312-316+321.